248 related articles for article (PubMed ID: 10571818)
1. p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma.
Sato A; MacHinami R
Pathol Int; 1999 Oct; 49(10):858-68. PubMed ID: 10571818
[TBL] [Abstract][Full Text] [Related]
2. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of chromogranin A and p53 expressions in ulcerative colitis-associated neoplasia: neuroendocrine differentiation as an early event in the colitis-neoplasia sequence.
Shigaki K; Mitomi H; Fujimori T; Ichikawa K; Tomita S; Imura J; Fujii S; Itabashi M; Kameoka S; Sahara R; Takenoshita S
Hum Pathol; 2013 Nov; 44(11):2393-9. PubMed ID: 24029705
[TBL] [Abstract][Full Text] [Related]
4. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
[TBL] [Abstract][Full Text] [Related]
5. Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia.
Gui X; Liu S; Yan Y; Gao Z
World J Gastroenterol; 2013 Jul; 19(28):4504-10. PubMed ID: 23901225
[TBL] [Abstract][Full Text] [Related]
6. Comparison of p53 immunoexpression with allelic loss of p53 in ulcerative colitis-associated dysplasia and carcinoma.
Fogt F; Zhuang Z; Poremba C; Dockhorn-Dworniczak B; Vortmeyer A
Oncol Rep; 1998; 5(2):477-80. PubMed ID: 9468583
[TBL] [Abstract][Full Text] [Related]
7. Metallothionein: early marker in the carcinogenesis of ulcerative colitis-associated colorectal carcinoma.
Bruewer M; Schmid KW; Krieglstein CF; Senninger N; Schuermann G
World J Surg; 2002 Jun; 26(6):726-31. PubMed ID: 12053227
[TBL] [Abstract][Full Text] [Related]
8. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
[TBL] [Abstract][Full Text] [Related]
9. Ulcerative colitis with overexpression of p53 preceding overt histological abnormalities of the epithelium.
Matsuda K; Watanabe H; Ajioka Y; Kobayashi M; Saito H; Sasaki M; Yasuda K; Kuwabara A; Nishikura K; Muto T
J Gastroenterol; 1996 Dec; 31(6):860-7. PubMed ID: 9027653
[TBL] [Abstract][Full Text] [Related]
10. Role of immunohistochemical markers in predicting progression of dysplasia to advanced neoplasia in patients with ulcerative colitis.
van Schaik FD; Oldenburg B; Offerhaus GJ; Schipper ME; Vleggaar FP; Siersema PD; van Oijen MG; Ten Kate FJ
Inflamm Bowel Dis; 2012 Mar; 18(3):480-8. PubMed ID: 21509910
[TBL] [Abstract][Full Text] [Related]
11. Comparison of genetic alterations in colonic adenoma and ulcerative colitis-associated dysplasia and carcinoma.
Fogt F; Vortmeyer AO; Goldman H; Giordano TJ; Merino MJ; Zhuang Z
Hum Pathol; 1998 Feb; 29(2):131-6. PubMed ID: 9490271
[TBL] [Abstract][Full Text] [Related]
12. The sharp decline of beta estrogen receptors expression in long-lasting ulcerative-associated carcinoma.
Principi M; Scavo MP; Piscitelli D; Villanacci V; Lovero R; Losurdo G; Girardi B; Ierardi E; Di Leo A
Scand J Gastroenterol; 2015 Aug; 50(8):1002-10. PubMed ID: 25862314
[TBL] [Abstract][Full Text] [Related]
13. Mutations of p53 in morphologically non-neoplastic mucosa of long-standing ulcerative colitis.
Takaku H; Ajioka Y; Watanabe H; Hashidate H; Yamada S; Yokoyama J; Kazama S; Suda T; Hatakeyama K
Jpn J Cancer Res; 2001 Feb; 92(2):119-26. PubMed ID: 11223540
[TBL] [Abstract][Full Text] [Related]
14. Dysplasia-like epithelial atypia in ischemic bowel disease.
Abraham SC; Taggart MW; Loftus EV; Wu TT
Hum Pathol; 2014 Jul; 45(7):1348-57. PubMed ID: 24946975
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
Fujii S; Fujimori T; Chiba T
J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
[TBL] [Abstract][Full Text] [Related]
16. Midkine expression in colorectal tumors: correlation with Ki-67 labeling in sporadic, but not ulcerative colitis-associated ones.
Tokuyama W; Mikami T; Fujiwara M; Matsui T; Okayasu I
Pathol Int; 2007 May; 57(5):260-7. PubMed ID: 17493173
[TBL] [Abstract][Full Text] [Related]
17. Diverse p53 alterations in ulcerative colitis-associated low-grade dysplasia: full-length gene sequencing in microdissected single crypts.
Yoshida T; Mikami T; Mitomi H; Okayasu I
J Pathol; 2003 Feb; 199(2):166-75. PubMed ID: 12533829
[TBL] [Abstract][Full Text] [Related]
18. Morphological Classification of Corrupted Colonic Crypts in Ulcerative Colitis.
Rubio CA; Schmidt PT
Anticancer Res; 2018 Apr; 38(4):2253-2259. PubMed ID: 29599347
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratin 7/20 and mucin core protein expression in ulcerative colitis-associated colorectal neoplasms.
Tatsumi N; Kushima R; Vieth M; Mukaisho K; Kakinoki R; Okabe H; Borchard F; Stolte M; Okanoue T; Hattori T
Virchows Arch; 2006 Jun; 448(6):756-62. PubMed ID: 16609910
[TBL] [Abstract][Full Text] [Related]
20. Assessment of dysplasia, mucosal mucins, p53 protein expression, and DNA content in ulcerative colitis patients with colectomy and ileorectal anastomosis.
Navratil E; Stettler C; Paul G; Vilotte J; Vissuzaine C; Mignon M; Potet F
Scand J Gastroenterol; 1995 Apr; 30(4):361-6. PubMed ID: 7610353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
